Richard George Khoury is a notable inventor based in Redwood City, California. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate protein kinase enzymatic activity. With a total of 12 patents to his name, Khoury's work has the potential to impact various cellular activities and therapeutic applications.

Latest Patents

One of Khoury's latest patents focuses on C-met modulators and methods of use. This invention provides compounds designed to modulate protein kinase enzymatic activity, which in turn influences cellular activities such as proliferation, differentiation, programmed cell death, migration, and chemoinvasion. Specifically, the invention includes quinazolines and quinolines that inhibit, regulate, and/or modulate kinase receptors, particularly c-Met, KDR, c-Kit, flt-3, and flt-4. These compounds are crucial for treating kinase-dependent diseases and conditions. Additionally, the patent outlines methods for creating these compounds and the compositions that contain them.

Career Highlights

Throughout his career, Richard Khoury has worked with prominent companies in the biotechnology sector, including Exelixis, Inc. and Exelixus, Inc. His experience in these organizations has allowed him to further his research and development efforts in innovative therapeutic solutions.

Collaborations

Khoury has collaborated with several professionals in his field, including Lynne Canne Bannen and John M Nuss. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Richard George Khoury's innovative work in the field of biotechnology, particularly in the area of protein kinase modulation, showcases his significant contributions to medical science. His patents and collaborations reflect a commitment to advancing therapeutic options for various diseases and conditions.

This text is generated by artificial intelligence and may not be accurate.